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Abstract
Background: Hemodialysis (HD) with ultrafiltration (UF) in chronic renal replacement therapy is associated with
hemodynamic instability, morbidity and mortality. Sublingual Sidestream Dark Field (SDF) imaging during HD
revealed reductions in microcirculatory blood flow (MFI). This study aims to determine underlying mechanisms.
Methods: The study was performed in the Medical Centre Leeuwarden and the Lithuanian University of Health
Sciences. Patients underwent 4-h HD session with linear UF. Nine patients were subject to combinations of HD and
UF: 4 h of HD followed by 1 h isolated UF and 4 h HD with blood-volume-monitoring based UF. Primary endpoint:
difference in MFI before and after intervention. During all sessions monitoring included blood pressure, heartrate
and SDF-imaging. Trial registration number: NCT01396980.
Results: Baseline characteristics were not different between the two centres as within the HD/UF modalities. MFI
was not different before and after HD with UF. Total UF did not differ between modalities. Median MFI decreased
significantly during isolated UF [2.8 (2.5–2.9) to 2.5 (2.2–2.8), p = 0.03]. Baseline MFI of each UF session was
correlated with MFI after the intervention (rs = 0.52, p = 0.006).
Conclusion: During HD with UF or isolated HD we observed no changes in MFI. This indicates that non-flow
mediated mechanisms are of unimportance. During isolated UF we observed a reduction in MFI in conjunction
with a negative intravascular fluid balance. The correlation between MFI before and after intervention suggests that
volume status at baseline is a factor in microvascular alterations. In conclusion we observed a significant decrease
of sublingual MFI, related to UF rate during chronic renal replacement therapy.
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Background
Intermittent hemodialysis (HD) with concomitant ultrafiltra-
tion (UF) in chronic renal replacement therapy is associated
with hemodynamic instability, usually referred to as ‘intra-
dialytic hypotension’. The incidence of this phenomenon
ranges between 30 and 90% depending on the definition on
clinically relevant intradialytic hypotension. This unfavour-
able condition is not only associated with the inability to
extract fluids adequately, but also with increased all-cause
mortality, hospitalization for heart failure/volume overload
and major adverse cardiac events [1–4]. In addition,
intradialytic hypotension is likely to represent the tip of the
iceberg with respect to consequences of changes in organ
perfusion during HD. A striking discordance between
hemodialysis-related symptoms or changes in (relative)
blood volume and intradialytic hypotension has been
reported [5, 6]. Intradialytic hypotension is more likely to
represent a late symptom of a pre-existing gradual reduction
in blood flow during HD, compensated by an increase in
vascular resistance and cardiac performance. However, pre-
existent cardiac morbidity and concomitant treatment is
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likely to disturb this compensation mechanisms. More
importantly, decreased left ventricular compliance as a result
of increased heart mass and a rapidly descending systemic
vascular resistance are both risk factors for a decreased
cardiac output and potentially hypotension in dialysis
patients [7]. Apart from non-circulatory effects of HD this
discordance also represents a fundamental problem within
the current clinical assumption that blood pressure is dir-
ectly related to organ perfusion. To overcome this prob-
lem direct visualisation and quantification of the
sublingual microcirculation with a hand-held device has
been suggested by Bemelmans and co-workers, as a non-
invasive tool to trace ‘organ’ perfusion during HD [8]. Dir-
ect in-vivo microscopy of the sublingual area with
sidestream dark field (SDF) imaging during HD revealed
marked reductions in microcirculatory blood flow in the
absence of intradialytic hypotension in the vast majority of
patients. Despite the potential of these observations many
questions remain to be answered. The incidence, aetiology
and clinical relevance of the microvascular alterations
remain to be elucidated. This study has 2 major objectives:
1. Are we able to reproduce previous observations in a
comparable subset of patients; and 2. Are the observed
microcirculatory alterations the result of UF, HD or a
combination?
Methods
Study design and setting
Phase I consisted of a multi-centre prospective observa-
tional study conducted between October 2011 and
December 2012. Participating centres were the Medical
Centre Leeuwarden, a tertiary teaching hospital in the
Netherlands and The Hospital of Lithuanian University of
Health Sciences, an academic medical centre in Kaunas,
Lithuania. Local ethical committees of both hospitals
approved the study and written informed consent was ob-
tained from every patient, according to applicable laws. In
phase II (2012) of the study all patients included in the
Netherlands were additionally subject to a single-centre
prospective interventional study to compare different
combinations of HD and UF rates. Study design was regis-
tered in advance at Clinicaltrials.gov (NCT01396980).
Intervention
In phase I all patients were subject to their routine 4-h
HD session, using a standard bicarbonate dialysate on
normal temperature. During this period linear UF was
maintained at a constant rate, in order to achieve a
quantitative ultrafiltrate target, based upon the regis-
tered ideal dry weight of the patient. Primary endpoint is
the difference in MFI between baseline and post
intervention.
In phase II patients from the Netherlands were subject
to 2 additional combinations of HD and UF: 4 h of HD
alone followed by 1 h isolated UF, and 4 h HD plus UF
based on blood-volume-monitoring (BVM) (5008
hemodialysis machine®, Fresenius Medical Care) (Fig. 1)
[9]. Sessions were assigned to each patient in random
order and performed on the same day of the week; every
patient served as his/her own reference. Primary end-
point is the difference in MFI between the HD/UF mo-
dalities post intervention.
Measurements
During all sessions standard hemodynamic monitoring
included blood pressure, heartrate and peripheral oxygen
saturation using pulse oximetry. Sublingual in-vivo
microscopy with sidestream dark field (SDF)-imaging,
incorporated in a small hand-held camera, was per-
formed in all patients at baseline and at the end of each
session. For each timeframe 3 steady images of at least
10 s were obtained and recorded on digital videotape
(SONY videowalkman GV-D 1000E®, Sony, Tokyo,
Japan). Subsequent analysis was performed off-line and
in random order with AVA software (Microvision
Medical, Amsterdam, the Netherlands) [10]. Quantifica-
tion of parameters of red blood cell velocity and capillary
density was performed in accordance with an inter-
national consensus paper [11]. In short, red blood cell
velocity in small vessels (<20 μm) is scored semi-
quantitatively for each quadrant between 0 (stand still)
and 3 (continuous normal flow) [12]. The average score
of 3 × 4 quadrants is expressed as microvascular flow
index (MFI). Total vessel density (TVD), as a determin-
ant of capillary density, is calculated as the surface area
of small vessels per mm2. Percentage of perfused vessels
(PPV) is expressed as the percentage of perfused
capillaries (MFI 2 and 3) divided by the total number of
Fig. 1 Study design. HD hemodialysis, UF ultrafiltration, BVM blood
volume monitoring
Veenstra et al. BMC Nephrology  (2017) 18:71 Page 2 of 6
capillaries that crosses a grid of three horizontal and
vertical equidistant lines. In phase II body composition
monitoring (BCM; Fresenius Medical, Bad Homburg,
Germany), based upon bioelectrical impedance analysis,
and measurements of N-terminal pro b-type natriuretic
peptide (NT-proBNP) and Troponine T were additionally
performed prior to and after each intervention [13, 14].
Statistics
All data are expressed as median [IQR]. Statistical analysis
was performed with the Statistical Package for Social
Sciences (SPSS 21, Chicago Illinois, USA). Due to the
small sample size non-parametric tests for independent
and paired data, as well as for correlation coefficients were
applicable. A p-value < 0.05 was considered statistically
significant. Based upon previous publications a sample
size of 8 patients for phase II was considered adequate to
detect a difference of 0.7 arbitrary units in MFI between
the different HD/UF modalities [8].
Results
Phase I
During a 15-months period in 2011–2012 28 pa-
tients were included in the study. Overall, baseline
characteristics were not significantly different be-
tween the 2 centres (Table 1). The primary endpoint
MFI was not different before and after HD in
combination with linear UF of 2.3 [1.3–3.2] l over a
4 h period (Table 2). In addition, hemodynamic vari-
ables did not change over time, with the exception
of a small, but significant increase in peripheral oxy-
gen saturation (Table 2).
Phase II
In a 2-month period in 2012 all 9 patients from the
Netherlands that participated in phase I were included.
There was no statistical difference between baseline
characteristics of different HD/UF modalities (Table 3).
Total UF did not differ between HD/UF modalities, with
the exception of HD alone. However, UF rate was signifi-
cantly higher in isolated UF (p < 0.001) in comparison to
combined HD/UF modalities (Table 3). Median MFI
decreased significantly during isolated UF [2.8 (2.5–2.9)
to 2.5 (2.2–2.8), p = 0.03], but remained unaltered during
the other HD/UF modalities. We observed no significant
difference between HD + linear UF and HD + BVM-
guide UF (Fig. 2). With the exception of isolated HD,
BCM-derived overhydration and NT-pro-BNP decreased
significantly during all HD/UF modalities, indicating a
similar trend in volume status.
Baseline MFI of each UF session (irrespective of UF
modality) was significantly correlated with MFI after the
intervention (rs = 0.52, p = 0.006; Fig. 3a). The coefficient
of correlation for pre- and post-intervention overhydra-
tion was also significant (rs = 0.75, p < 0.001; Fig. 3b).
Table 1 Baseline characteristics phase I and II
Variables All (n = 28) LT (n = 19) NL (n = 9) p-value
Men, % 57 42 89 0.04
Age, years 64 [53–74] 60 [49–70] 69 [55–78] 0.29
Years on HD 3 [1–6] 3 [1–7] 3 [1–5] 0.94
Remaining diuresis, l/24 h 0.2 [0–0.5] 0.3 [0–0.6] 0.2 [0–0.4] 0.60
Weight, kg 78 [67–87] 73 [66–79] 85 [88–92] 0.03
BMI, kg/m2 26 [24–28] 27 [23–30] 26 [25–28] 0.94
UF volume, l 2.3 [1.3–3.2] 2.6 [1.6–3.3] 1.7 [1.2–2.1] 0.10
Cause of ESRD, %
Diabetes 32 21 56
Hypertension 18 26 0
ADPKD 7 5 11 0.27
ATN 14 16 11
Miscellaneous 29 32 22
Drugs, %
ß-blocker 61 42 67 1.0
ACE inhibitor 61 74 33 0.1
Calcium antagonist 47 58 22 0.09
LT Lithuania, NL Netherlands, HD hemodialysis, BMI body mass index, UF ultrafiltration, ESRD end stage renal disease, ADKPD autosomal dominant polycystic
kidney disease, ATN acute tubular necrosis, ACE angiotensin converting enzyme
Veenstra et al. BMC Nephrology  (2017) 18:71 Page 3 of 6
Discussion
In phase I of the study we did not observe a reduction in
sublingual microvascular blood flow or capillary density
during HD in combination with linear UF. In an attempt
to unravel the aetiology of previously observed alterations
in microvascular blood flow during combined HD/UF we
changed the ultrafiltration modalities in a subset of
patients in phase II. During isolated HD we observed no
changes in microvascular blood flow. This indicates that
potential non-flow mediated mechanisms for microvascu-
lar derangements, such as hemodialysis-induced inflam-
mation and hypercoagulation, are unlikely to play an
important role [15, 16]. However, during isolated UF, a
modality with the highest UF rate in which the influence of
HD itself is absent, we were indeed able to reproduce the
reduction in microvascular blood flow, as observed by
others [8, 17]. This suggests that the observed reduction in
microvascular blood flow may be the result of a negative
intravascular fluid balance. In case the UF rate exceeds the
ability to mobilize interstitial fluids towards the intravascu-
lar space, an increase in vascular resistance or viscosity
causes a reduction in microvascular blood flow. The fact
that Bemelmans et al. observed a marked attenuation of
impaired microvascular blood flow during autotransfusion
with a Trendelenburg manoeuvre after HD/UF is also in
line with this aetiology [8].
An important issue is the question why we did not
observe previously reported microcirculatory alterations
during HD in combination with linear UF. At first glance
there are important similarities with both articles: UF was
2.5 [1.6–3.5] l and 2.5 ± 0.88 l respectively, and over a
similar period of time [8, 17]. But a closer look reveals a
marked reduction in MFI at baseline in both studies; 2.8
[2.5–5] and 2.7 ± 0.5 versus 3 [2.8–3] in our study.
Baseline values of these previous publications indicate
pre-existing microvascular derangement prior to the start
of HD/UF, since they are outside the range of healthy
volunteers [18, 19]. A secondary analysis of our data in
phase II revealed a significant correlation between MFI at
baseline and MFI after the intervention, indicating that
indeed volume status at baseline is an additional factor in
Table 3 Results phase II (n = 9). Laboratory data, microcirculatory
variables of small vessels (<20 μm) and bioelectrical impedance
analysis before and after intervention
Variables Baseline Post-intervention p-value
UF isolated
UF - 1.7 [1.2–2]
UF rate, l/h - 1.7 [1.2–2]†
MFI, AU 2.8 [2.5–2.9] 2.5 [2.2–2.8] 0.03
TVD, mm/mm2 17.7 [16.5–18.4] 18.7 [16.1–20.3] 0.26
Hematocrit, % 37 [35–39] 39 [36–44] 0.11
NT-pro-BNP, pmol/l 599 [215–1702] 580 [158–1440] 0.01
Troponine T, ng/l 90 [60–150] 87 [56–130] 0.08
BCM overhydration, l 1.4 [0.6–3.2] 0.3 [−0.1–0.8] 0.02
HD isolated
UF – 0 [0–0]
UF rate, l/h – 0 [0–0]†
MFI, AU 2.8 [2.5–2.9] 2.8 [2.7–2.9] 0.61
TVD, mm/mm2 17.7 [16.5–18.4] 18.6 [14.6–19.7] 0.86
Hematocrit, % 37 [35–39] NA
NT-pro-BNP, pmol/l 599 [215–1702] NA
Troponine T, ng/l 90 [60–150] NA
BCM overhydration, l 1.4 [0.6–3.2] NA
HD + linear UF
UF 1.7 [1.2–2.1]
UF rate, l/h 0.42 [0.3–5.1]†
MFI, AU 2.9 [2.5–3] 2.6 [2.2–2.9] 0.12
TVD, mm/mm2 17.8 [16.6–18.8] 19.8 [17.9–21.5] 0.07
Hematocrit, % 38 [35–40] 40 [35–41] 0.18
T-pro-BNP, pmol/l 618 [279–1926] 536 [167–1003] 0.01
Troponine T, ng/l 94 [61–179] 84 [62–139] 0.02
BCM overhydration, l 1.8 [0.5–5.3] 0.3 [−0.9–3.2] 0.02
HD + BVM-guided UF
UF 2.0 [1.5–2.1]
UF rate, l/h 0.5 [0.39–0.52]†
MFI, AU 2.8 [2.5–3] 2.8 [1.9–2.9] 0.06
TVD, mm/mm2 18.8 [16.8–20.6] 18.2 [16.9–20.6] 0.77
Hematocrit, % 37 [34–39] 39 [35–42] 0.12
NT-pro-BNP, pmol/l 574 [229–2011] 511 [172–1163] 0.01
Troponine T, ng/l 81 [54–379] 79 [54–387] 0.12
BCM overhydration, l 2.4 [1.5–5.1] 0.2 [−0.9–4.2] 0.04
UF ultrafiltration, HD hemodialysis, BVM blood volume monitoring, MFI
microvascular flow index, TVD total vessel density, PPV percentage of perfused
vessels, NT-pro-BNP n-terminal pro b-type natriuretic peptide, BCM body
composition monitoring †p < 0.001 across different HD/UF modalities
Table 2 Results phase I (n= 28). Hemodynamic and microcirculatory
variables of small vessels (<20 μm) before and after hemodialysis in
combination with linear ultrafiltration
Variables Baseline Post HD/UF p-value
Mean arterial pressure, mmHg 93 [76–111] 96 [84–110] 0.39
Heartrate, beats/min 69 [62–80] 73 [60–84] 0.24
SpO2, % 97 [96–98] 98 [98–99] 0.009
MFI, AU 3 [2.8–3] 3 [2.8–3] 0.55
TVD, mm/mm2 22.2 [18–29.8] 22.7 [19.9–29] 0.11
PPV, % 98 [96–100] 98 [96–99] 0.35
HD hemodialysis, UF ultrafiltration, SpO2 peripheral oxygen saturation, MFI
microvascular flow index, AU arbitrary units, TVD total vessel density, PVD
perfused vessel density, PPV percentage of perfused vessel
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the development of microvascular alterations during UF,
irrespective of its modality. This suggest that our pa-
tients were less prone for microcirculatory changes,
but that a higher rate of isolated ultrafiltration can
result in impaired microperfusion in this group. Fur-
thermore, our data suggest that 56% of the post-
intervention overhydration is caused by pre-treatment
overhydration (Fig. 3b).
Further studies are needed to investigate a potential
correlation between ultrafiltration-derived changes in
microvascular flow and morbidity and/or mortality in
hemodialysis patients.
The limitations of the study are related to the small
sample size in phase II. We anticipated a potential differ-
ence in MFI between the UF modalities, based upon previ-
ous observations. However, the observed changes in MFI
were considerably smaller. As a consequence we may have
been unable to detect an existing difference in sublingual
microvascular blood flow between HD+ linear UF and HD
+BVM-guided UF (type I error).
Conclusions
In conclusion we observed a significant decrease of sub-
lingual microvascular blood flow due to rapid isolated
ultrafiltration. Additional interventions with different
combinations of HD and UF revealed that HD per se is
not associated with changes in microvascular flow. Dur-
ing ultrafiltration over a longer period of time, and in
combination with hemodialysis, baseline abnormalities
were associated abnormal microvascular blood flow at
the end of the renal replacement session. By design this
study is not suitable to establish the clinical relevance of
the observed microvascular alterations.
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